other_bg

Products

Food Grade Liposomal Nicotinamide Riboside NR 50% Powder Advanced Encapsulation Clean Label Wellness CAS 1341-23-7

Short Description:

Nicotinamide Riboside (NR) is a Vitamin B3 derivative and direct dietary precursor to nicotinamide adenine dinucleotide (NAD+) — a coenzyme essential to mitochondrial energy metabolism and cellular redox balance. However, unencapsulated NR presents well-documented handling challenges: pronounced hygroscopicity accelerates moisture-driven degradation, and rapid dissolution in aqueous environments complicates blend uniformity.


Product Detail

Product Tags

NAD+ Precursor Ingredient

LIPOSOMAL NICOTINAMIDE RIBOSIDE

Nicotinamide Riboside (NR) is a Vitamin B3 derivative and direct dietary precursor to nicotinamide adenine dinucleotide (NAD+) — a coenzyme essential to mitochondrial energy metabolism and cellular redox balance. However, unencapsulated NR presents well-documented handling challenges: pronounced hygroscopicity accelerates moisture-driven degradation, and rapid dissolution in aqueous environments complicates blend uniformity. Liposomal encapsulation addresses both. By enclosing NR (CAS 1341-23-7) within phospholipid bilayer vesicles — the same molecular architecture found in all cell membranes — this delivery system creates a moisture-protective micro-environment and modulates release behavior during manufacturing. The result is NR powder engineered for predictable performance across capsule, tablet, and beverage powder workflows. Available at 50% and 70% loading.

CAS 1341-23-7
50% & 70% Loading
Liposomal Delivery
Clean Label Ready
Liposomal Nicotinamide Riboside NR Powder

TECHNICAL SPECIFICATIONS
Product Name Liposomal Nicotinamide Riboside (NR) Powder
Chemical Name 3-(Aminocarbonyl)-1-β-D-ribofuranosylpyridinium chloride
Active Loading 50% Standard Grade|70% High-Potency Grade
CAS Number 1341-23-7
Encapsulation Efficiency ≥ 80% (Typical)
Particle Size 80–300 nm (Rehydrated)
PDI ≤ 0.35
Appearance Off-white to pale yellow powder
Solubility Dispersible in water (stable liposomal suspension)
LOD ≤ 5.0%
Heavy Metals (as Pb) ≤ 10 ppm
Storage Cool, dry, sealed; protect from light and moisture
Shelf Life Refer to batch-specific COA

WHY LIPOSOMAL NR?

NR and the NAD+ Salvage Pathway

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, cycling between oxidized and reduced states to shuttle electrons in enzymatic reactions — most critically within the mitochondrial electron transport chain. NAD+ is consumed continuously and must be replenished through endogenous biosynthesis.

NR enters this system via the NAD+ salvage pathway: NR is first phosphorylated by nicotinamide riboside kinases (NRK1/2) to NMN, then converted to NAD+ by NMN adenylyltransferase. This two-step biochemical route is one of the body’s endogenous mechanisms for maintaining cellular NAD+ availability.

The Formulation Challenge

The same nucleoside structure that enables NR’s cellular uptake also makes it inherently hygroscopic — absorbing atmospheric moisture during storage, blending, and capsule filling. In humid production environments, unencapsulated NR can exhibit visible caking, color shifts, and active-content drift within weeks of opening bulk containers.

Furthermore, NR’s aqueous solubility creates difficulties in wet-granulation and multi-phase beverage powder systems, where rapid, non-uniform dissolution can introduce content-variability issues batch to batch.

How Liposomal Encapsulation Helps

(1) Moisture Barrier. The phospholipid bilayer physically separates encapsulated NR from ambient humidity. While not an absolute seal, this lipid barrier slows moisture ingress — reducing hydrolytic degradation during manufacturing steps where controlled-humidity conditions are impractical.

(2) Controlled Aqueous Release. Liposomal vesicles swell gradually upon rehydration rather than bursting instantly. This modulated release supports more uniform blend distribution in wet-granulation and beverage premix operations.

(3) QC-Verified Quality. EE% ≥ 80% by dialysis/HPLC confirms genuine encapsulation — distinguishing this product from simple physical blends of NR with phospholipids. DLS particle sizing verifies consistent nano-scale vesicle dimensions (80–300 nm) across every batch.

Liposomal NR NAD+ Salvage Pathway Diagram

KEY ADVANTAGES

1. Hygroscopicity Protection — Real-World Formulation

NR’s moisture sensitivity is a practical problem — not a theoretical one. Unencapsulated NR shows visible caking and active-content drift within weeks. The phospholipid bilayer acts as a diffusion barrier, slowing water-vapor contact. For humid-climate manufacturers or extended production campaigns, this means more predictable batch performance and less waste.

2. Dual Loading: 50% & 70%

50% offers balanced dosing for B3-complex, NAD+ precursor blends, and multivitamins. 70% maximizes NR per gram — enabling smaller capsules, fewer units per serving, and high-potency single-active products. Both grades share identical QC protocols and CoA documentation.

3. Verified Encapsulation — Beyond Blending

EE% ≥ 80% measured by dialysis/HPLC distinguishes true liposomal NR from simple dry blends of NR plus phospholipids. This analytical verification is documented on every CoA — not a one-off claim but a routine QC checkpoint.

4. DLS Particle Size — Why Nano-Scale Matters

Consistent 80–300 nm vesicles (PDI ≤ 0.35) indicate well-controlled emulsification and spray-drying. Larger or polydisperse populations suggest process variability that could affect rehydration and release behavior. DLS is run on every batch as a routine QC checkpoint.

QUALITY VERIFICATION

1. HPLC Active Assay

Every batch tested to confirm 50% or 70% NR loading. Batch-specific CoA provided with each shipment.

2. DLS Particle Size Analysis

Confirms stable liposome formation (80–300 nm) upon rehydration, verifying uniform nano-scale vesicle dimensions across production lots.

3. Encapsulation Efficiency (EE%)

EE% ≥ 80% by dialysis/HPLC confirms genuine liposomal encapsulation rather than simple physical blending with phospholipids.

4. Heavy Metal & Microbial Screening

Full compliance: Pb ≤ 10 ppm, As/Cd ≤ 1 ppm, Hg ≤ 0.1 ppm; TPC / Yeast & Mold per USP; E. coli and Salmonella negative per 25g.

WELLNESS APPLICATIONS

These statements describe established nutritional roles of Nicotinamide Riboside using structure/function language. They have not been evaluated by regulatory authorities. This product is not intended to diagnose, treat, cure, or prevent any disease.

NR Wellness Applications

1. Cellular Energy Metabolism — The NAD+ Connection

NR is a dietary NAD+ precursor, feeding into the same coenzyme system that drives mitochondrial oxidative phosphorylation — the primary ATP-generating pathway. A foundational ingredient in energy-support and metabolic-wellness supplement lines for active-lifestyle consumers.

2. Premium B3-Complex Differentiation

Within the Vitamin B3 family, NR’s pyridine-nucleoside structure sets it apart from nicotinic acid and nicotinamide. A differentiated, premium-positioned ingredient for B3-complex and NAD+ precursor supplement formulations targeting informed wellness consumers.

3. Cellular Redox Balance

NAD+ and NADH constitute a fundamental redox couple in cellular biochemistry, participating in hundreds of oxidoreductase reactions. By contributing as a dietary NAD+ precursor, NR supports the body’s endogenous NAD+/NADH balance mechanisms.

4. Daily Wellness & General Nutrition

As a recognized Vitamin B3-family member with a clear NAD+ precursor identity, NR fits naturally into broad-spectrum multivitamins, B-complex blends, and general-wellness supplement formulations. Science-grounded narrative supports consumer-facing product communication.

FORMULATION APPLICATIONS
NR Capsule Manufacturing Application
NR Powder Premix Application

1. B-Complex & Multivitamin Capsules

50% grade integrates into multi-component B-complex and NAD+ precursor blend capsules. 200–450 mg fill weights; compatible with high-speed capsule filling lines.

2. High-Potency Single-Active NR

70% grade enables 100–300 mg active NR per compact capsule — optimizing capsule dimensions and packaging-to-active ratios for single-active NR supplement SKUs.

3. Functional Beverage Premixes

Both grades compatible with stick packs, sachets, and powdered drink mixes. The liposomal carrier supports more uniform dispersion and rehydration in multi-phase beverage powder systems.

4. Premium Multivitamin & Wellness Stacks

NR as a differentiated B3-family ingredient in comprehensive multivitamin and wellness-stack formulations. Compatible with capsule, tablet, and powder formats. Non-GMO phospholipid sourcing supports clean-label positioning.

OEM & PACKING
OEM Service

OEM & CUSTOM FORMULATION

Certifications

CERTIFICATIONS

Transportation

TRANSPORTATION

Packaging

PACKAGING

TECHNICAL FAQ
Q1: What is the difference between EE% and Active Loading?
+

Active Loading (50% or 70%) measures total NR content per gram by weight. Encapsulation Efficiency (EE%) measures the proportion genuinely enclosed within liposome vesicles versus physically blended with phospholipids. EE% ≥ 80% confirms true liposomal formulation delivering meaningful encapsulation benefits — not simply NR powder mixed with phospholipids.

Q2: How does liposomal encapsulation help with NR’s hygroscopicity?
+

NR is naturally hygroscopic — it absorbs moisture from the air. The phospholipid bilayer of liposomal vesicles acts as a physical diffusion barrier that slows water-vapor contact with the encapsulated NR payload. While not an absolute moisture-proof seal, this barrier reduces the rate of humidity-driven degradation during storage, blending, and capsule filling — particularly relevant for manufacturers in humid production environments.

Q3: What does DLS particle size data tell me about product quality?
+

Dynamic Light Scattering (DLS) measures the hydrodynamic diameter of rehydrated liposomal vesicles. Consistent 80–300 nm dimensions with narrow polydispersity (PDI ≤ 0.35) indicate well-controlled emulsification and spray-drying — translating to predictable rehydration and release behavior batch to batch. Larger or highly variable particle populations suggest process inconsistency that may affect formulation behavior across production lots.


  • Previous:
  • Next: